In Brief
- The pregnancy point of care testing market grew at a steady value CAGR of 3.7% during 2013-2017, as low availability and product penetration of pregnancy point of care testing products in emerging economies impacted the market growth.
- In 2018, the pregnancy point of care testing market reached US$ 1.2 billion and, with growing awareness about infertility disorders and increasing healthcare spending across the world, the market is expected to witness 5.0% y-o-y in 2019.
- The global pregnancy point of care testing market is likely to envisage incremental growth at a healthy 4.5% CAGR during the forecast period 2018-2028. Technological advancements and awareness about the accuracy and efficiency of pregnancy point of care testing products will contribute to increasing growth of the market during the assessment period.
- Backed by strong presence of leading market players in the U.S., North America will continue to remain the leading market for pregnancy point of care testing products throughout the forecast period.
- South Asia is expected to emerge as a high-growth market for pregnancy point of care testing with lucrative opportunities for product penetration and increasing preference for home monitoring devices for ovulation tracker among end-users in South Asian countries.
Note: For more extensive insights into the global pregnancy point of care testing market, request a sample.
What are the Key Growth Drivers of Pregnancy Point of Care Testing Market?
- Growing prevalence of gynecological issues and fertility disorders, coupled with high preference for fast and self-contained tests is primarily boosting sales of pregnancy point of care testing products.
- Increasing awareness about the availability of technologically advanced and high-precision pregnancy point of care testing products is providing an impetus to market growth.
- Manufacturers are adopting next-generation technologies to introduce advanced features, such as accuracy and ease of use, and improve the reliability of pregnancy point of care testing products.
- Leading players in the pregnancy point of care testing market are launching products with smartphone connectivity to attract modern customers and boost adoption of smart pregnancy point of care testing products.
Note: To gain detailed information on growth drivers of pregnancy point of care testing market, request a sample.
What are the Key Challenges in the Pregnancy Point of Care Testing Market?
- An increasing number of new entrants in the pregnancy point of care testing market are introducing innovative products at competitive prices. A huge price gap between new market players’ and leading players’ products will impact growth of the global pregnancy point of care testing products.
- Questions raised on the accuracy of pregnancy point of care testing products and the possibility of getting inaccurate results is restricting consumers to rely on these products, consequently hampering growth of the market.
- Stringent regulations and standards along with lengthy certification processes, developed by governing bodies influence salient business strategies. Strict product approval rules also make a significant impact on the manufacturing cost of pregnancy point of care testing products, creating challenges for manufacturers at introducing products at competitive prices in the market.
Pregnancy Point of Care Testing Market – Notable Developments
- In December 2018, Quidel Corporation – an American manufacturer of point of care testing and diagnostics healthcare products – announced that it is resuming the manufacturing of Quidel Triage® Placental Growth Factor (PLGF) Test, a biomarker for placental dysfunction, which will be available in the U.S. markets in 2019. It claims that the Quidel Triage PLGF Test can help healthcare professionals to accurately risk-stratify pregnant women with the help of an accurate as well as early diagnosis of preterm pre-eclampsia. The company also announced that the ownership of the Triage PLGF Test product transferred to Quidel after the company acquired Alere Inc.’s Triage® business. By reintroducing the Triage PLGF test product, the company aims to expand its presence in the pregnancy point of care testing market in the coming years.
- In July 2018, NOW Diagnostics Inc. – a U.S.-based player active in the point of care testing market – announced that it has acquired Cellmic LLC – a U.S.-based manufacturer of mobile-phone-based holographic imaging and diagnostics – to strengthen its position in the rapid diagnostics and mobile health space. By integrating Cellamic’s advanced reader technology with its point of care testing platform, NOW Diagnostics aims to improve accuracy, ease of use, convenience, and cost-efficiency of its point of care testing products, with this acquisition.
- In October 2017, Swiss Precision Diagnostics (SPD) GmbH – a Swiss medical diagnostic company owned by Procter & Gamble – announced that it has introduced a new pregnancy point of care test, which is an ovulation testing system that can be synced with a smartphone application, under its ovulation brand Clearblue®. The company also announced that the new Clearblue® Connected Ovulation Test System is a urine test, which adapts and tracks the levels of LH and estrogen, and accurately compares to an ultrasound.
- In March 2019, Group K Diagnostics Inc. – a biotechnology company in the point of care testing market – announced that it is designing and developing a point of care Zika assay in collaboration with the Centers for Disease Control and Prevention (CDC). The company also announced that it is one of the important goals of the collaboration with CDC is to offer a rapid point of care testing tool that can also be used by women living in areas at risk of ZIKV transmission throughout pregnancy for prenatal care.
- In September 2018, Sugentech, Inc. – a South Korean manufacturer of pregnancy point of care testing products – announced that it has expanded its distributors’ network in North America. The company announced that it established a collaboration with CGETC, Inc. in 2017 to distribute its products in the U.S., and now its products are available in the country through Amazon.com. The company aims to capitalize on the increasing growth of the pregnancy point of care testing market in the U.S. by strengthening its distribution capacities in the North American region.
Abbott Laboratories
Abbott Laboratories was established in 1888 and is headquartered in Tokyo, Japan. Abbott Laboratories is one of the leading healthcare company in the world that offers a wide range of in vitro diagnostic products. The company acquired Alere, Inc. and St. Jude’s Medical, Inc. in 2017, and aims to continue expanding in emerging economies through acquisition strategies in the upcoming years.
Quidel Corporation
Established in 1987, Quidel Corporation is headquartered in California, U.S., and the company manufactures and markets rapid diagnostic test products. Quidel Corporation’s products mainly cover women’s health and gastrointestinal diseases, and therapeutic areas of infectious diseases. Its products are distributed and marketed under various brands, such as Quidel, QuickVue, Micro Vue, Fresh Cells, and Sofia.
Swiss Precision Diagnostics (SPD) GmbH
Founded in 2007, Swiss Precision Diagnostics (SPD) GmbH is headquartered in Geneva, Switzerland and is a leading provider of consumer diagnostic products. The company was established as a joint venture between Alere Inc. (Abbott Laboratories) and Procter & Gamble (P&G), which are two leading manufacturers of consumer diagnostics products. The company supplies its diagnostic products through its brands including Clearblue, Persona, Fact Plus, Crystal Clear, and Accu-Clear.
NOW Diagnostics Inc.
Founded in 1939 and headquartered in Bentonville, AR, U.S., NOW Diagnostics Inc. is a leader in innovative diagnostic health testing market. The company offers an hCG (human chorionic gonadotropin) test— ADEXUSDx® hCG Test—in Europe and the United States, and two cardiac tests and three toxicology tests in Europe.
Church & Dwight Co. Inc.
Church & Dwight Co. Inc. was founded in 1846 and it is headquartered in New Jersey, U.S. The company offers its personal care products under the range of over 80 of its flagship brands, including FIRST RESPONSE™. The company operates through its three business divisions – specialty products, consumer domestic, and consumer international. The company launched its first Bluetooth-enabled digital pregnancy PRO test in 2016, and it aims to expand its presence in countries outside the U.S. with a major focus on mergers and acquisition.
Abbott Laboratories, Quidel Corporation, Prestige Brands Holdings, Swiss Precision Diagnostics (SPD) GmbH, Church & Dwight Co., Inc., BIOSYNEX SA, EKF Diagnostics Holdings plc, NOW Diagnostics Inc, NG BIOTECH SAS, ulti med Products (Deutschland) GmbH, Procter & Gamble Co., Piramal Enterprises, bioMérieux SA, Atlas Medical UK, and Home Health (UK) Ltd are among the key companies in the pregnancy point of care testing market.
Note: To gain more information on the competitive landscape in the agricultural sprayers market, get the summary of this report.
Pregnancy Point of Care Testing Market – Additional Insight
Pregnancy Test Kits Selling Higher than Fertility Test Kits
The preliminary 2016 data released by the Centers for Disease Control and Prevention shows that more women are delaying their first pregnancy, as the birth rate among women in their 30s surpassed that among women in their 20s, in 2015. Social norms vis-à-vis the age of motherhood have changed in developed countries with remarkable speed, especially among highly-educated women. Increasing concerns about women’s health and pregnancy are triggering the adoption of pregnancy test kits among women.
Moreover, low levels of awareness about fertility issues and reproductive health, especially in developing nations, is restricting the sales of fertility test kits. In addition, concerns about the accuracy of at-home fertility test kits limits the adoption of fertility test kits. On the contrary, the ease of use and technological advancements in pregnancy test kits has been boosting its demand, marking an emerging trend in the pregnancy point of care testing market.
Scope of the Report
Research Methodology
The Fact.MR research study on pregnancy point of care testing market offers industry-best intelligence and insights into the global pregnancy point of care testing market forecast. The research study on pregnancy point of care testing market is a result of extensive research methodology, comprising of a primary phase and a secondary phase. The report on pregnancy point of care testing market gives a comprehensive analysis of its growth prospects and opportunities over the forecast period, including a detailed segmentation.
Request research methodology of this Report.
Pregnancy Point of Care Testing Market: A Detailed Analysis of Important Growth Prospects
Fact.MR recently published a market study, “Pregnancy Point of Care Testing Market: Global Industry Analysis and Opportunity Assessment, 2018-2028”. This report features the most critical growth prospects of the pregnancy point of care testing market. The market report presents thorough information and it elucidates how the pregnancy point of care testing market will expand during the assessment period 2018-2028 with the help of important market dynamics.
The report includes unique and accurate information on salient growth prospects of the pregnancy point of care testing market to help stakeholders to make value-based business decisions. Important indicators of the pregnancy point of care testing market growth, which include value chain analysis, Compound Annual Growth Rate (CAGR), Year-on-Year (Y-o-Y) growth, and supply chain analysis, are assessed thoroughly in the report to understand the growth prospects of the pregnancy point of care testing market for the assessment period.
On assessing industry-validated data, market-related facts, and important data about the global expansion of the pregnancy point of care testing market, unique and comprehensive information about the growth prospects of the pregnancy point of care testing market is presented in a seamless format in the report. The information featured in the report is segmented into chapters to offer a comprehensive structure to the pregnancy point of care testing market report.
Chapter 1 – Executive Summary
This chapter provides the outlook of key growth prospects as a results of thorough analysis on the pregnancy point of care testing market. The chapter includes comprehensive information about demand side trends, supply side trends, and technology roadmap associated with the pregnancy point of care testing market. It also provides quick insights on the summary of global pregnancy point of care testing demand and supply across the world.
Chapter 2 – Market Overview
Definition of pregnancy point of care testing market is included in this chapter along with a detailed introduction to pregnancy point of care testing market with the help of the market structure. This chapter offers an information on prospects the pregnancy point of care testing market will grow during 2018-2028 in terms of value (US$ billion) and volume (units).
Chapter 3 – Key Market Trends
This chapter provides thorough information about key trends in the pregnancy point of care testing market and how these trends will influence prospects of the market in coming future.
Chapter 4 – Pregnancy Point of Care Testing – Key Inclusions
This chapter include important information global development indicators, such as fertility rate, which may impact growth of the pregnancy point of care market. The section also covers global development indicators for fertility rate and sensitivity chart for various pregnancy point of care testing products by major brands available in the market. Readers can also find detailed comparison of the sales and demand for pregnancy test kits and fertility test kits, in this chapter.
Chapter 5 – Pregnancy Point of Care Testing Market Volume Analysis, 2013–2017 and Forecast 2018–2028
This chapter processes information about historic growth parameters and future prospects of the pregnancy point of care testing market in terms of volume (units). The chapter also provides information about Y-o-Y growth trend analysis and global average pricing analysis benchmark for the forecast period 2018-2028.
Chapter 6 – Global Pregnancy Point of Care Testing Market - Pricing Analysis
In this chapter, readers can find thorough analysis of the pregnancy point of care testing pricing depending on types, regions, and pricing break-up through 2028, along with the information associated with factors that are affecting pricing of pregnancy point of care testing available across the world.
Chapter 7 - Pregnancy Point of Care Testing Market Value Analysis, 2013–2017 and Forecast 2018–2028
This chapter processes information about historic growth parameters and future prospects of the pregnancy point of care testing market in terms of value (US$ million). The chapter also provides information about Y-o-Y growth trend analysis and global average pricing analysis benchmark for the forecast period 2018-2028.
Chapter 8 – Market Background
The chapter also shed lights on current industry trends in the pregnancy point of care testing industry and analysis on adoption of pregnancy point of care testing across various industrial sectors to help readers in understanding various other factors that can influence growth of the pregnancy point of care testing market. This chapter includes market dynamics, Porter’s five forces analysis supply chain analysis, regional price point analysis, and value chain analysis.
Chapter 9 – Global Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028, By Region
This chapter explains how growth prospects of the pregnancy point of care testing market change based on geographical regions, such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East and Africa.
Chapter 10 – Global Pregnancy Point of Care Testing Analysis 2013–2017 and Forecast 2018–2028, By Product Type
This chapter explains how growth prospects of the pregnancy point of care testing market change based on the product types of pregnancy point of care testing, such as pregnancy test kits and fertility test kits. Pregnancy test kits are further segmented in strips/ dipsticks and cards, midstream kits, cassettes, and digital devices. Fertility test kits are segmented into line-indicator kits and digital devices.
Chapter 11 – Global Pregnancy Point of Care Testing Analysis 2013–2017 and Forecast 2018–2028, By Test Type
This chapter explains how growth prospects of the pregnancy point of care testing market change based on the test types, which include LH urine, FSH urine, hCG blood, and hCG urine.
Chapter 12 – Global Pregnancy Point of Care Testing Analysis 2013–2017 and Forecast 2018–2028, By Sample Type
This chapter explains how growth prospects of the pregnancy point of care testing market change based on the sample types used in design pregnancy point of care testing products, such as urine and blood.
Chapter 13 – Global Pregnancy Point of Care Testing Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
This chapter explains how growth prospects of the pregnancy point of care testing market change based on the distribution channels, which include pharmacy, drugstores, online sales, hypermarkets and supermarkets, and gynecology/fertility clinics.
Chapter 14 – North America Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
In this chapter, information on how pregnancy point of care testing market will grow in North American region during 2018-2028 is included. Readers can also find growth prospects of the North America pregnancy point of care testing market in the United States and Canada in terms of market value (US$ billion) and volume (units) by 2028.
Chapter 15 – Latin America Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
Information about growth of the pregnancy point of care testing market in Latin American region during 2018-2028 is featured in this chapter. Growth prospects of the pregnancy point of care testing market in Latin America in terms of market value (US$ billion) and volume (units) by 2028 are also included. The market value assessment by country, including Brazil and Mexico, is featured in the chapter.
Chapter 16 – Europe Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
Readers can also find growth prospects of the pregnancy point of care testing market in Europe, based on the estimates on market value (US$ billion) and volume (units) by 2028. Readers can find critical growth prospects of the pregnancy point of care testing market in the leading countries in Europe such as Germany, France, UK, Spain, Italy, BENELUX, and Russia.
Chapter 17 – South Asia Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
Readers can also find growth prospects of the pregnancy point of care testing market in South Asia, based on the estimates on market value (US$ billion) and volume (units) by 2028. Readers can find critical growth prospects of the pregnancy point of care testing market in the leading South Asian countries, including India, Thailand, Malaysia, and Indonesia.
Chapter 18 – East Asia Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
Readers can also find growth prospects of the pregnancy point of care testing market in East Asia, based on the estimates on market value (US$ billion) and volume (units) by 2028. Readers can find critical growth prospects of the pregnancy point of care testing market in the leading East Asian countries, including China, Japan, and South Korea.
Chapter 19 – Oceania Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
Readers can also find growth prospects of the pregnancy point of care testing market in Oceania in terms of market value (US$ billion) and volume (units) by 2028. Readers can find critical growth prospects of the pregnancy point of care testing market in the leading countries, including Australia and New Zealand.
Chapter 20 – MEA Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
This chapter focusses on growth prospects of the pregnancy point of care testing market in the Middle East and Africa region, based on the estimates on market value (US$ billion) and volume (units) by 2028. This chapter provides readers with detailed information on growth of the pregnancy point of care testing market in major countries in MEA region, such as GCC Countries, North Africa, and South Africa, during the forecast period.
Chapter 21 – China Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
This chapter offers detailed information about the growth of the pregnancy point of care testing market in China during the forecast period, based on product types, test types, sample types, and distribution channels.
Chapter 22 – Japan Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
This chapter offers detailed information about the growth of the pregnancy point of care testing market in Japan during the forecast period, based on product types, test types, sample types, and distribution channels.
Chapter 23 – India Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
This chapter offers detailed information about the growth of the pregnancy point of care testing market in India during the forecast period, based on product types, test types, sample types, and distribution channels.
Chapter 24 – Forecast Factors: Relevance and Impact
This chapter provides several forecast factors considered in the pregnancy point of care testing market report. Impact of these forecast factors on the pregnancy point of care testing market is also mentioned in this section.
Chapter 25 – Forecast Assumptions
This section covers all the major forecast assumptions taken into consideration for market analysis of pregnancy point of care testing.
Chapter 26 – Market Structure Analysis
This chapter also provides critical information about pregnancy point of care testing market structure, financial share analysis key financials, and competitive developments of each stakeholder in the pregnancy point of care testing market. This can help them to comprehend insights about the competitive landscape in the pregnancy point of care testing market with information about leading and emerging stakeholders in the market.
Chapter 27 – Competition Analysis
Abbott Laboratories, Quidel Corporation, Prestige Brands Holdings, Swiss Precision Diagnostics (SPD) GmbH, Church & Dwight Co., Inc., BIOSYNEX SA, EKF Diagnostics Holdings plc, NOW Diagnostics Inc, NG BIOTECH SAS, ulti med Products (Deutschland) GmbH, Procter & Gamble Co., Piramal Enterprises, bioMérieux SA, Atlas Medical UK, and Home Health (UK) Ltd are among the key companies in the pregnancy point of care testing market.
Chapter 28 – Assumption and Acronyms Used
Important acronyms and assumptions are featured in the last chapter of the Fact.MR report on pregnancy point of care testing market, which can help readers to ensure to appropriate understanding of the information featured in the report.
Chapter 29 – Research Methodology
Important information about the research methodology is featured in this chapter.
1. Executive Summary
1.1. Market Outlook
1.2. Market Analysis
1.3. Market Dynamics
1.4. Technology Roadmap
1.5. FMR Analysis and Recommendations
2. Market Overview
2.1. Market Introduction
2.2. Parent Market Assessment
2.3. Market Definition
2.4. Market Taxonomy
3. Key Market Trends
3.1. Market Trends, By Region
3.2. Macro-economic Indicators
3.3. Key Regulations, By Region
4. Pregnancy Point of Care Testing – Key Inclusions
4.1. Product Comparison, By Pregnancy Test Kits
4.2. Product Comparison, By Fertility Test Kits
4.3. Global Development Indicators, Fertility rate
4.4. Pregnancy Point of Care Testing, Key Insights
4.5. Sensitivity Chart for Pregnancy Test Kits
5. Global Pregnancy Point of Care Testing Market Volume Analysis, 2013–2017 and Forecast 2018–2028
5.1. Market Volume Projections
5.2. Y-o-Y Growth Analysis and Absolute $ Opportunity
6. Global Pregnancy Point of Care Testing Market - Pricing Analysis
6.1. Pricing Analysis, By Product Type
7. Global Pregnancy Point of Care Testing Market Value Analysis, 2013–2017 and Forecast 2018–2028
7.1. Market Value Projections
7.2. Y-o-Y Growth Analysis and Absolute $ Opportunity
8. Market Background
8.1. Market Dynamics
8.1.1. Drivers
8.1.2. Restraints
8.1.3. Opportunities
9. Global Pregnancy Point of Care Testing Analysis 2013–2017 and Forecast 2018–2028, By Region
9.1. Introduction/Key Findings
9.2. Historical Market Value (US$ Mn) Analysis By Region, 2013–2017
9.2.1. North America
9.2.2. Latin America
9.2.3. Europe
9.2.4. South Asia
9.2.5. East Asia
9.2.6. Oceania
9.2.7. Middle East & Africa
9.3. Market Value (US$ Mn) Forecast By Region, 2018–2028
9.4. Market Attractiveness Analysis By Region
10. Global Pregnancy Point of Care Testing Analysis 2013–2017 and Forecast 2018–2028, By Product Type
10.1.Introduction/Key Findings
10.2.Historical Market Value (US$ Mn) Analysis By Product Type, 2013–2017
10.2.1. Pregnancy Test Kits
10.2.1.1. Strips/ Dipsticks and Cards
10.2.1.2. Midstream Kits
10.2.1.3. Cassettes
10.2.1.4. Digital Devices
10.2.2. Fertility Test Kits
10.2.2.1. Line-Indicator Kits
10.2.2.2. Digital Devices
10.3.Market Value (US$ Mn) Forecast By Product Type, 2018–2028
10.4.Market Attractiveness Analysis By Product Type
11. Global Pregnancy Point of Care Testing Analysis 2013–2017 and Forecast 2018–2028, By Test Type
11.1.Introduction/Key Findings
11.2.Historical Market Value (US$ Mn) Analysis By Test Type, 2013–2017
11.2.1. LH Urine
11.2.2. FSH Urine
11.2.3. hCG Blood
11.2.4. hCG Urine
11.3.Market Value (US$ Mn) Forecast By Test Type, 2018–2028
11.4.Market Attractiveness Analysis By Test Type
12. Global Pregnancy Point of Care Testing Analysis 2013–2017 and Forecast 2018–2028, By Sample Type
12.1.Introduction/Key Findings
12.2.Historical Market Value (US$ Mn) Analysis By Sample Type, 2013–2017
12.2.1. Urine
12.2.2. Blood
12.3.Market Value (US$ Mn) Forecast By Sample Type, 2018–2028
12.4.Market Attractiveness Analysis By Sample Type
13. Global Pregnancy Point of Care Testing Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
13.1.Introduction/Key Findings
13.2.Historical Market Value (US$ Mn) Analysis By Distribution Channel, 2013–2017
13.2.1. Pharmacy
13.2.2. Drugstores
13.2.3. Online Sales
13.2.4. Hypermarkets and Supermarkets
13.2.5. Gynecology/ Fertility Clinics
13.3.Market Value (US$ Mn) Forecast By Distribution Channel, 2018–2028
13.4.Market Attractiveness Analysis By Distribution Channel
14. North America Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
14.1.Introduction
14.2.Historical Market Value (US$ Mn) and Volume Analysis By Countries 2013–2017
14.2.1. U.S.
14.2.2. Canada
14.3.Market Value (US$ Mn) and Volume Analysis Forecast By Countries, 2018–2028
14.4.Historical Market Value (US$ Mn) and Volume Analysis By Product Type 2013–2017
14.4.1. Pregnancy Test Kits
14.4.1.1. Strips/ Dipsticks and Cards
14.4.1.2. Midstream Kits
14.4.1.3. Cassettes
14.4.1.4. Digital Devices
14.4.2. Fertility Test Kits
14.4.2.1. Line-Indicator Kits
14.4.2.2. Digital Devices
14.5.Market Value (US$ Mn) and Volume Analysis Forecast By Product Type, 2018–2028
14.6.Historical Market Value (US$ Mn) Analysis By Test Type 2013–2017
14.6.1. LH Urine
14.6.2. FSH Urine
14.6.3. hCG Blood
14.6.4. hCG Urine
14.7.Market Value (US$ Mn) Analysis Forecast By Test Type, 2018–2028
14.8. Historical Market Value (US$ Mn) Analysis By Sample Type 2013–2017
14.8.1. Urine
14.8.2. Blood
14.9.Market Value (US$ Mn) Analysis Forecast By Sample Type, 2018–2028
14.10. Historical Market Value (US$ Mn) Analysis By Distribution Channel 2013–2017
14.10.1. Pharmacy
14.10.2. Drugstores
14.10.3. Online Sales
14.10.4. Hypermarkets and Supermarkets
14.10.5. Gynecology/ Fertility Clinics
14.11. Market Value (US$ Mn) Analysis Forecast By Distribution Channel, 2018–2028
14.12. Market Attractiveness Analysis
14.12.1. By Country
14.12.2. By Product Type
14.12.3. By Test Type
14.12.4. By Sample Type
14.12.5. By Distribution Channel
14.13. Drivers & Restraints – Impact Analysis
15. Latin America Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
15.1.Introduction
15.2.Historical Market Value (US$ Mn) and Volume Analysis By Countries 2013–2017
15.2.1. Brazil
15.2.2. Mexico
15.2.3. Rest of Latin America
15.3.Market Value (US$ Mn) and Volume Analysis Forecast By Countries, 2018–2028
15.4.Historical Market Value (US$ Mn) and Volume Analysis By Product Type 2013–2017
15.4.1. Pregnancy Test Kits
15.4.1.1. Strips/ Dipsticks and Cards
15.4.1.2. Midstream Kits
15.4.1.3. Cassettes
15.4.1.4. Digital Devices
15.4.2. Fertility Test Kits
15.4.2.1. Line-Indicator Kits
15.4.2.2. Digital Devices
15.5. Market Value (US$ Mn) and Volume Analysis Forecast By Product Type, 2018–2028
15.6. Historical Market Value (US$ Mn) Analysis By Test Type 2013–2017
15.6.1. LH Urine
15.6.2. FSH Urine
15.6.3. hCG Blood
15.6.4. hCG Urine
15.7. Market Value (US$ Mn) Analysis Forecast By Test Type, 2018–2028
15.8. Historical Market Value (US$ Mn) Analysis By Sample Type 2013–2017
15.8.1. Urine
15.8.2. Blood
15.9. Market Value (US$ Mn) Analysis Forecast By Sample Type, 2018–2028
15.10. Historical Market Value (US$ Mn) Analysis By Distribution Channel 2013–2017
15.10.1. Pharmacy
15.10.2. Drugstores
15.10.3. Online Sales
15.10.4. Hypermarkets and Supermarkets
15.10.5. Gynecology/ Fertility Clinics
15.11. Market Value (US$ Mn) Analysis Forecast By Distribution Channel, 2018–2028
15.12. Market Attractiveness Analysis
15.12.1. By Country
15.12.2. By Product Type
15.12.3. By Test Type
15.12.4. By Sample Type
15.12.5. By Distribution Channel
15.13. Drivers & Restraints – Impact Analysis
16. Europe Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
16.1. Introduction
16.2. Historical Market Value (US$ Mn) and Volume Analysis By Countries 2013–2017
16.2.1. Germany
16.2.2. Italy
16.2.3. France
16.2.4. U.K
16.2.5. Spain
16.2.6. BENELUX
16.2.7. Russia
16.2.8. Rest of Europe
16.3. Market Value (US$ Mn) and Volume Analysis Forecast By Countries, 2018–2028
16.4. Historical Market Value (US$ Mn) and Volume Analysis By Product Type 2013–2017
16.4.1. Pregnancy Test Kits
16.4.1.1. Strips/ Dipsticks and Cards
16.4.1.2. Midstream Kits
16.4.1.3. Cassettes
16.4.1.4. Digital Devices
16.4.2. Fertility Test Kits
16.4.2.1. Line-Indicator Kits
16.4.2.2. Digital Devices
16.5. Market Value (US$ Mn) and Volume Analysis Forecast By Product Type, 2018–2028
16.6. Historical Market Value (US$ Mn) Analysis By Test Type 2013–2017
16.6.1. LH Urine
16.6.2. FSH Urine
16.6.3. hCG Blood
16.6.4. hCG Urine
16.7. Market Value (US$ Mn) Analysis Forecast By Test Type, 2018–2028
16.8. Historical Market Value (US$ Mn) Analysis By Sample Type 2013–2017
16.8.1. Urine
16.8.2. Blood
16.9. Market Value (US$ Mn) Analysis Forecast By Sample Type, 2018–2028
16.10. Historical Market Value (US$ Mn) Analysis By Distribution Channel 2013–2017
16.10.1. Pharmacy
16.10.2. Drugstores
16.10.3. Online Sales
16.10.4. Hypermarkets and Supermarkets
16.10.5. Gynecology/ Fertility Clinics
16.11. Market Value (US$ Mn) Analysis Forecast By Distribution Channel, 2018–2028
16.12. Market Attractiveness Analysis
16.12.1. By Country
16.12.2. By Product Type
16.12.3. By Test Type
16.12.4. By Sample Type
16.12.5. By Distribution Channel
16.13. Drivers & Restraints – Impact Analysis
17. South Asia Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
17.1. Introduction
17.2. Historical Market Value (US$ Mn) and Volume Analysis By Countries 2013–2017
17.2.1. Thailand
17.2.2. Indonesia
17.2.3. Malaysia
17.2.4. India
17.2.5. Rest of South Asia
17.3. Market Value (US$ Mn) and Volume Analysis Forecast By Countries, 2018–2028
17.4. Historical Market Value (US$ Mn) and Volume Analysis By Product Type 2013–2017
17.4.1. Pregnancy Test Kits
17.4.1.1. Strips/ Dipsticks and Cards
17.4.1.2. Midstream Kits
17.4.1.3. Cassettes
17.4.1.4. Digital Devices
17.4.2. Fertility Test Kits
17.4.2.1. Line-Indicator Kits
17.4.2.2. Digital Devices
17.5. Market Value (US$ Mn) and Volume Analysis Forecast By Product Type, 2018–2028
17.6. Historical Market Value (US$ Mn) Analysis By Test Type 2013–2017
17.6.1. LH Urine
17.6.2. FSH Urine
17.6.3. hCG Blood
17.6.4. hCG Urine
17.7. Market Value (US$ Mn) Analysis Forecast By Test Type, 2018–2028
17.8. Historical Market Value (US$ Mn) Analysis By Sample Type 2013–2017
17.8.1. Urine
17.8.2. Blood
17.9. Market Value (US$ Mn) Analysis Forecast By Sample Type, 2018–2028
17.10. Historical Market Value (US$ Mn) Analysis By Distribution Channel 2013–2017
17.10.1. Pharmacy
17.10.2. Drugstores
17.10.3. Online Sales
17.10.4. Hypermarkets and Supermarkets
17.10.5. Gynecology/ Fertility Clinics
17.11. Market Value (US$ Mn) Analysis Forecast By Distribution Channel, 2018–2028
17.12. Market Attractiveness Analysis
17.12.1. By Country
17.12.2. By Product Type
17.12.3. By Test Type
17.12.4. By Sample Type
17.12.5. By Distribution Channel
17.13. Drivers & Restraints – Impact Analysis
18. East Asia Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
18.1. Introduction
18.2. Historical Market Value (US$ Mn) and Volume Analysis By Countries 2013–2017
18.2.1. South Korea
18.2.2. China
18.2.3. Japan
18.3. Market Value (US$ Mn) and Volume Analysis Forecast By Countries, 2018–2028
18.4. Historical Market Value (US$ Mn) and Volume Analysis By Product Type 2013–2017
18.4.1. Pregnancy Test Kits
18.4.1.1. Strips/ Dipsticks and Cards
18.4.1.2. Midstream Kits
18.4.1.3. Cassettes
18.4.1.4. Digital Devices
18.4.2. Fertility Test Kits
18.4.2.1. Line-Indicator Kits
18.4.2.2. Digital Devices
18.5. Market Value (US$ Mn) and Volume Analysis Forecast By Product Type, 2018–2028
18.6. Historical Market Value (US$ Mn) Analysis By Test Type 2013–2017
18.6.1. LH Urine
18.6.2. FSH Urine
18.6.3. hCG Blood
18.6.4. hCG Urine
18.7. Market Value (US$ Mn) Analysis Forecast By Test Type, 2018–2028
18.8. Historical Market Value (US$ Mn) Analysis By Sample Type 2013–2017
18.8.1. Urine
18.8.2. Blood
18.9.Market Value (US$ Mn) Analysis Forecast By Sample Type, 2018–2028
18.10. Historical Market Value (US$ Mn) Analysis By Distribution Channel 2013–2017
18.10.1. Pharmacy
18.10.2. Drugstores
18.10.3. Online Sales
18.10.4. Hypermarkets and Supermarkets
18.10.5. Gynecology/ Fertility Clinics
18.11. Market Value (US$ Mn) Analysis Forecast By Distribution Channel, 2018–2028
18.12. Market Attractiveness Analysis
18.12.1. By Country
18.12.2. By Product Type
18.12.3. By Test Type
18.12.4. By Sample Type
18.12.5. By Distribution Channel
18.13. Drivers & Restraints – Impact Analysis
19. Oceania Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
19.1. Introduction
19.2. Historical Market Value (US$ Mn) and Volume Analysis By Countries 2013–2017
19.2.1. Australia
19.2.2. New Zealand
19.3. Market Value (US$ Mn) and Volume Analysis Forecast By Countries, 2018–2028
19.4. Historical Market Value (US$ Mn) and Volume Analysis By Product Type 2013–2017
19.4.1. Pregnancy Test Kits
19.4.1.1. Strips/ Dipsticks and Cards
19.4.1.2. Midstream Kits
19.4.1.3. Cassettes
19.4.1.4. Digital Devices
19.4.2. Fertility Test Kits
19.4.2.1. Line-Indicator Kits
19.4.2.2. Digital Devices
19.5. Market Value (US$ Mn) and Volume Analysis Forecast By Product Type, 2018–2028
19.6. Historical Market Value (US$ Mn) Analysis By Test Type 2013–2017
19.6.1. LH Urine
19.6.2. FSH Urine
19.6.3. hCG Blood
19.6.4. hCG Urine
19.7. Market Value (US$ Mn) Analysis Forecast By Test Type, 2018–2028
19.8. Historical Market Value (US$ Mn) Analysis By Sample Type 2013–2017
19.8.1. Urine
19.8.2. Blood
19.9. Market Value (US$ Mn) Analysis Forecast By Sample Type, 2018–2028
19.10. Historical Market Value (US$ Mn) Analysis By Distribution Channel 2013–2017
19.10.1. Pharmacy
19.10.2. Drugstores
19.10.3. Online Sales
19.10.4. Hypermarkets and Supermarkets
19.10.5. Gynecology/ Fertility Clinics
19.11. Market Value (US$ Mn) Analysis Forecast By Distribution Channel, 2018–2028
19.12. Market Attractiveness Analysis
19.12.1. By Country
19.12.2. By Product Type
19.12.3. By Test Type
19.12.4. By Sample Type
19.12.5. By Distribution Channel
19.13. Drivers & Restraints – Impact Analysis
20. MEA Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
20.1. Introduction
20.2. Historical Market Value (US$ Mn) Analysis By Countries 2013–2017
20.2.1. GCC Countries
20.2.2. Northern Africa
20.2.3. South Africa
20.2.4. Rest of MEA
20.3. Market Value (US$ Mn) Analysis Forecast By Countries, 2018–2028
20.4. Historical Market Value (US$ Mn) and Volume Analysis By Product Type 2013–2017
20.4.1. Pregnancy Test Kits
20.4.1.1. Strips/ Dipsticks and Cards
20.4.1.2. Midstream Kits
20.4.1.3. Cassettes
20.4.1.4. Digital Devices
20.4.2. Fertility Test Kits
20.4.2.1. Line-Indicator Kits
20.4.2.2. Digital Devices
20.5. Market Value (US$ Mn) and Volume Analysis Forecast By Product Type, 2018–2028
20.6.Historical Market Value (US$ Mn) Analysis By Test Type 2013–2017
20.6.1. LH Urine
20.6.2. FSH Urine
20.6.3. hCG Blood
20.6.4. hCG Urine
20.7. Market Value (US$ Mn) Analysis Forecast By Test Type, 2018–2028
20.8. Historical Market Value (US$ Mn) Analysis By Sample Type 2013–2017
20.8.1. Urine
20.8.2. Blood
20.9.Market Value (US$ Mn) Analysis Forecast By Sample Type, 2018–2028
20.10. Historical Market Value (US$ Mn) Analysis By Distribution Channel 2013–2017
20.10.1. Pharmacy
20.10.2. Drugstores
20.10.3. Online Sales
20.10.4. Hypermarkets and Supermarkets
20.10.5. Gynecology/ Fertility Clinics
20.11. Market Value (US$ Mn) Analysis Forecast By Distribution Channel, 2018–2028
20.12. Market Attractiveness Analysis
20.12.1. By Country
20.12.2. By Product Type
20.12.3. By Test Type
20.12.4. By Sample Type
20.12.5. By Distribution Channel
20.13. Drivers & Restraints – Impact Analysis
21. China Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
21.1. Introduction
21.2. Historical Market Value (US$ Mn) and Volume Analysis By Product Type 2013–2017
21.2.1. Pregnancy Test Kits
21.2.1.1. Strips/ Dipsticks and Cards
21.2.1.2. Midstream Kits
21.2.1.3. Cassettes
21.2.1.4. Digital Devices
21.2.2. Fertility Test Kits
21.2.2.1. Line-Indicator Kits
21.2.2.2. Digital Devices
21.3. Market Value (US$ Mn) and Volume Analysis Forecast By Product Type, 2018–2028
21.4. Historical Market Value (US$ Mn) and Volume Analysis By Test Type 2013–2017
21.4.1. LH Urine
21.4.2. FSH Urine
21.4.3. hCG Blood
21.4.4. hCG Urine
21.5. Market Value (US$ Mn) and Volume Analysis Forecast By Test Type, 2018–2028
21.6. Historical Market Value (US$ Mn) and Volume Analysis By Sample Type 2013–2017
21.6.1. Urine
21.6.2. Blood
21.7. Market Value (US$ Mn) and Volume Analysis Forecast By Sample Type, 2018–2028
21.8. Historical Market Value (US$ Mn) and Volume Analysis By Distribution Channel 2013–2017
21.8.1. Pharmacy
21.8.2. Drugstores
21.8.3. Online Sales
21.8.4. Hypermarkets and Supermarkets
21.8.5. Gynecology/ Fertility Clinics
21.9. Market Value (US$ Mn) and Volume Analysis Forecast By Distribution Channel, 2018–2028
21.10. Market Attractiveness Analysis
21.10.1. By Product Type
21.10.2. By Test Type
21.10.3. By Sample Type
21.10.4. By Distribution Channel
21.11. Drivers & Restraints – Impact Analysis
22. Japan Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
22.1. Introduction
22.2. Historical Market Value (US$ Mn) and Volume Analysis By Product Type 2013–2017
22.2.1. Pregnancy Test Kits
22.2.1.1. Strips/ Dipsticks and Cards
22.2.1.2. Midstream Kits
22.2.1.3. Cassettes
22.2.1.4. Digital Devices
22.2.2. Fertility Test Kits
22.2.2.1. Line-Indicator Kits
22.2.2.2. Digital Devices
22.3. Market Value (US$ Mn) and Volume Analysis Forecast By Product Type, 2018–2028
22.4. Historical Market Value (US$ Mn) and Volume Analysis By Test Type 2013–2017
22.4.1. LH Urine
22.4.2. FSH Urine
22.4.3. hCG Blood
22.4.4. hCG Urine
22.5. Market Value (US$ Mn) and Volume Analysis Forecast By Test Type, 2018–2028
22.6. Historical Market Value (US$ Mn) and Volume Analysis By Sample Type 2013–2017
22.6.1. Urine
22.6.2. Blood
22.7. Market Value (US$ Mn) and Volume Analysis Forecast By Sample Type, 2018–2028
22.8. Historical Market Value (US$ Mn) and Volume Analysis By Distribution Channel 2013–2017
22.8.1. Pharmacy
22.8.2. Drugstores
22.8.3. Online Sales
22.8.4. Hypermarkets and Supermarkets
22.8.5. Gynecology/ Fertility Clinics
22.9. Market Value (US$ Mn) and Volume Analysis Forecast By Distribution Channel, 2018–2028
22.10. Market Attractiveness Analysis
22.10.1. By Product Type
22.10.2. By Test Type
22.10.3. By Sample Type
22.10.4. By Distribution Channel
22.11. Drivers & Restraints – Impact Analysis
23. India Pregnancy Point of Care Testing Market Analysis 2013–2017 and Forecast 2018–2028
23.1. Introduction
23.2. Historical Market Value (US$ Mn) and Volume Analysis By Product Type 2013–2017
23.2.1. Pregnancy Test Kits
23.2.1.1. Strips/ Dipsticks and Cards
23.2.1.2. Midstream Kits
23.2.1.3. Cassettes
23.2.1.4. Digital Devices
23.2.2. Fertility Test Kits
23.2.2.1. Line-Indicator Kits
23.2.2.2. Digital Devices
23.3. Market Value (US$ Mn) and Volume Analysis Forecast By Product Type, 2018–2028
23.4. Historical Market Value (US$ Mn) and Volume Analysis By Test Type 2013–2017
23.4.1. LH Urine
23.4.2. FSH Urine
23.4.3. hCG Blood
23.4.4. hCG Urine
23.5. Market Value (US$ Mn) and Volume Analysis Forecast By Test Type, 2018–2028
23.6. Historical Market Value (US$ Mn) and Volume Analysis By Sample Type 2013–2017
23.6.1. Urine
23.6.2. Blood
23.7. Market Value (US$ Mn) and Volume Analysis Forecast By Sample Type, 2018–2028
23.8. Historical Market Value (US$ Mn) and Volume Analysis By Distribution Channel 2013–2017
23.8.1. Pharmacy
23.8.2. Drugstores
23.8.3. Online Sales
23.8.4. Hypermarkets and Supermarkets
23.8.5. Gynecology/ Fertility Clinics
23.9. Market Value (US$ Mn) and Volume Analysis Forecast By Distribution Channel, 2018–2028
23.10. Market Attractiveness Analysis
23.10.1. By Product Type
23.10.2. By Test Type
23.10.3. By Sample Type
23.10.4. By Distribution Channel
23.11. Drivers & Restraints – Impact Analysis
24. Forecast Factors: Relevance and Impact
25. Forecast Assumptions
26. Market Structure Analysis
26.1. Market Analysis by Tier of Companies (Global Pregnancy Point of Care Testing)
26.2. Market Share Analysis of Top Players
27. Competition Analysis
27.1. Competition Dashboard
27.2. Competition Deep Dive
27.2.1. Abbott Laboratories
27.2.2. Quidel Corporation
27.2.3. Prestige Brands Holdings
27.2.4. Swiss Precision Diagnostics (SPD) GmbH
27.2.5. Church & Dwight Co., Inc.
27.2.6. BIOSYNEX SA
27.2.7. EKF Diagnostics Holdings plc
27.2.8. NOW Diagnostics Inc
27.2.9. NG BIOTECH SAS
27.2.10. ulti med Products (Deutschland) GmbH
27.2.11. Procter & Gamble Co.
27.2.12. Piramal Enterprises
27.2.13. bioMérieux SA
27.2.14. Atlas Medical UK
27.2.15. Home Health (UK) Ltd
28. Assumptions and Acronyms Used
29. Research Methodology
Fact.MR offers custom research services that help clients to get specific research solutions
Related reports
We are committed towards customer satisfaction and quality service.
Our Clients
Pregnancy Point of Care Testing Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 - 2028